TrialThe Journal of clinical endocrinology and metabolism2022

LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia.

Daniel J Rader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.